Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Kao

SAT0235 BIIB059, a Monoclonal Antibody Targeting BCDA2 Shows Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteer Subjects

2017English

Related publications

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2020English

Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2013English

Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects

Clinical Drug Investigation
MedicinePharmacology
2020English

FRI0315 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Biib059, a Monoclonal Antibody Targeting Bdca2 Following Intravenous (IV) and Subcutaneous (SC) Single or Multiple Doses Administration in Healthy Volounteers (HV) and Subjects With Active Systemic Lupus Erythematosus (SLE)

2018English

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Low Dose Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers

Psychopharmacology
Pharmacology
2019English

Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects

Clinical Drug Investigation
MedicinePharmacology
2015English

Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese and Non-Asian Male Subjects

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy